Jiangxi Fushine Pharmaceutical Co Ltd Asset Resilience Ratio

Latest as of June 2026: 0.02%

Jiangxi Fushine Pharmaceutical Co Ltd asset resilience ratio. Jiangxi Fushine Pharmaceutical Co Ltd (300497) has an Asset Resilience Ratio of 0.02% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Jiangxi Fushine Pharmaceutical Co Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥816.50K

≈ $119.48K USD Cash + Short-term Investments

Total Assets

CN¥4.69 Billion

≈ $686.05 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Jiangxi Fushine Pharmaceutical Co Ltd (2011–2025)

Asset resilience ratio of Jiangxi Fushine Pharmaceutical Co Ltd from 2011 to 2025. This chart shows how Jiangxi Fushine Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read Jiangxi Fushine Pharmaceutical Co Ltd (300497) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Jiangxi Fushine Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 300497 current and non-current assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥816.50K	0.02%
Total Liquid Assets	CN¥816.50K	0.02%

Asset Resilience Insights

Limited Liquidity: Jiangxi Fushine Pharmaceutical Co Ltd maintains only 0.02% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Jiangxi Fushine Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Jiangxi Fushine Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	36.07%
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
3SBio Inc F:83B	Biotechnology	10.64%

Jiangxi Fushine Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2011–2025)

Jiangxi Fushine Pharmaceutical Co Ltd asset resilience ratio by year from 2011 to 2025. The table below shows the annual Asset Resilience Ratio data for Jiangxi Fushine Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.02%	CN¥954.50K ≈ $139.67K	CN¥4.40 Billion ≈ $644.55 Million	-0.03pp
2024-12-31	0.05%	CN¥2.19 Million ≈ $319.73K	CN¥4.54 Billion ≈ $663.89 Million	+0.00pp
2023-12-31	0.05%	CN¥2.19 Million ≈ $319.73K	CN¥4.82 Billion ≈ $705.18 Million	-0.94pp
2022-12-31	0.98%	CN¥49.74 Million ≈ $7.28 Million	CN¥5.06 Billion ≈ $740.41 Million	-2.24pp
2021-12-31	3.22%	CN¥150.76 Million ≈ $22.06 Million	CN¥4.68 Billion ≈ $684.61 Million	+0.59pp
2020-12-31	2.64%	CN¥106.68 Million ≈ $15.61 Million	CN¥4.05 Billion ≈ $592.01 Million	+2.97pp
2019-12-31	-0.33%	CN¥-8.69 Million ≈ $-1.27 Million	CN¥2.60 Billion ≈ $379.85 Million	-0.17pp
2018-12-31	-0.17%	CN¥-3.72 Million ≈ $-544.44K	CN¥2.20 Billion ≈ $321.41 Million	-0.18pp
2017-12-31	0.01%	CN¥114.11K ≈ $16.70K	CN¥1.79 Billion ≈ $261.85 Million	-12.15pp
2016-12-31	12.16%	CN¥170.00 Million ≈ $24.88 Million	CN¥1.40 Billion ≈ $204.63 Million	+12.15pp
2013-12-31	0.00%	CN¥13.23K ≈ $1.94K	CN¥541.31 Million ≈ $79.21 Million	-0.02pp
2011-12-31	0.03%	CN¥96.12K ≈ $14.07K	CN¥352.57 Million ≈ $51.59 Million	--

pp = percentage points

About Jiangxi Fushine Pharmaceutical Co Ltd

SHE:300497 China Biotechnology

Market Cap

$1.08 Billion

CN¥7.40 Billion CNY

Market Cap Rank

#8260 Global

#1877 in China

Share Price

CN¥13.73

Change (1 day)

-2.07%

52-Week Range

CN¥13.12 - CN¥23.34

All Time High

CN¥24.76